More about
Silmitasertib
News
January 25, 2022
1 min read
Save
FDA grants orphan drug designation to silmitasertib for biliary tract cancer
The FDA granted orphan drug designation to silmitasertib for treatment of biliary tract cancer.
News
December 21, 2021
1 min read
Save